Abstract
Anti-centromere antibody (ACA) has been reported to be associated with Sjogren’s syndrome (SS) and the clinical significance of anti-CENP-H antibody remains unknown. To determine the clinical significance of anti-CENP-H and anti-centromere antibodies in primary SS, sera from 62 patients with primary SS and 40 normal controls were examined for anti-SS-A/SS-B antibodies, ACA and anti-CENP-H antibodies, by enzyme-linked immunosorbent assay and indirect immunofluorescence (IIF), respectively. Of the 62 serum samples with primary SS, 17 were positive with ACA and anti-CENP-H antibodies. Sera from SS patients with anti-CENP-H and ACA antibodies do not contain anti-SS-A/Ro and/or anti-SS-B/La antibodies. No anti-CENP-H antibody was found in sera of normal controls. An increased frequency of ACA and anti-CENP-H antibodies was found for the first time in patients with SS. Anti-CENP-H antibodies and anti-SS-A/Ro or anti-SS-B/La antibodies are present mutually exclusive. Patients with anti-CENP-H antibodies had a lower frequency of rheumatoid factor (RF). SS can be subdivided serologically into two groups; group one with anti-SS-A/Ro and/or anti-SS-B/La antibody, group two with ACA and/or anti-CENP-H antibodies. We recommend that ACA or anti-CENP-H antibodies should be considered as one of the serological markers for SS.
Similar content being viewed by others
References
Moroi Y, Peebles C, Fritzler MF, Steigrwald J, Tan EM (1980) Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natal Acad Sci USA 77:1627–1631
Tan EM, Rodana GP, Garcia I, Moroi Y, Fritzler M J, Peebles C (1980) Diversity of antinuclear antibodies in progressive systemic sclerosis: anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum 23:617–625
Bernstein RM, Callender ME, Neuberger JM, Hughes CRV, Williams R (1982) Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis 41:612–614
Lee SL, Tsay GJ, Tsai RT (1993) Anticentromere antibodies in subjects with no apparent connective tissue disease. Ann Rheum Dis 52:586–589
Kallenberg CG, Pastoor GW, Wouda AA, The TH (1982) Antinuclear antibodies in patients with Raynaud’s phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis 41:382–387
Fritzler MJ, Kinsella TD, Garbutt E (1980) The CREST syndrome: a distinct serologic entity with anticentromere antibodys. Am J Med 69:520–526
Skibbens RV, Hieter P (1998) Kinetochores and the checkpoint mechanism that monitors for defects in the chromere segregation machinery. Annu Rev Genet 32:249–262
Sugata N, Munekata E, and Todokoro K (1999) Characterization of a Novel Kinetochore Protein, CENP-H. J Biol Chem 274:27343–27346
Vafa O, Shelby RD, Sullivan KF (1999) CENP-A associated complex satellite DNA in the kinetochore of the Indian muntjac. Chromosoma 108:367–374
Sullivan KF, Glass CA (1991) CENP-B is a highly conserved mammalian centromere protein with homology to the helix–loop–helix family of proteins. Chromosoma 100:360–370
Fukagawa T, Mikami Y, Nishihashi A, Regnier V, Haraguchi T, Hiraoka Y, Sugata N, Todokoro K, Brown W, Ikemura T (2001) CENP-H, a constitutive centromere component, is required for centromere targeting of CENP-C in vertebrate cells. EMBO J 20:4603–4617
Sugata N, Li S, Earnshaw WC, Yen TJ, Yoda K, Masumoto H, Munekata E, Warburton PE, Todokoro K (2000) Human CENP-H multimers colocalize with CENP-A and CENP-C at active centromere–kinetochore complexes. Hum Mol Genet 9:2919–2926
Caramaschi P, Biasi D, Carletto A, Manzo T, Randon M, Zeminian S, Bambara LM (1997) Sjogren’s syndrome with anticentromere antibodies. Rev Rhum Engl Ed 64:785–788
Hida A, Kawabe Y, Kawakami A, Migita K, Tominaga M, Nakamura H, Eguchi K. (1999) HTLV-I associated Sjogren’s syndrome is aetiologically distinct from anti-centromere antibodies positive Sjogren’s syndrome. Ann Rheum Dis 58:320–322
Katano K, Kawano M, Koni I, Sugai S, Muro Y (2001) Clinical and laboratory features of anticentromere antibody positive primary Sjogren’s syndrome. J Rheumatol 28:2238–2244
Vlachoyiannopoulos PG, Drosos AA, Wiik A, Moutsopoulos HM (1993) Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol 32:297–301
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554–558
Wu YY, Hsu TC, Chen TY, Liu TC, Liu GY, Lee YJ, Tsay GJ (2002) Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection. Clin Exp Immunol 128:347–352
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354
Tsay GJ, Lan JL, Li SY (1992) Chromosome studies in systemic sclerosis with consideration of antibodies to topoisomerase I. Ann Rheum Dis 51:624–626
Tan EM (1982) Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 33:167–240
Earnshaw W, Bordwell B, Marino C, Rothfield N (1986) Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies. J Clin Invest 77:426–430
Acknowledgements
This study was supported by the Chung Shan Medical University CSMC 89-OM-B-003, 90-OM-B-012, and a grant NSC 91–2314-B040–013 from the National Science Council, Taiwan. S.-T. Liu is a Greenwald Fellow, Fox Chase Cancer Center, Philadelphia, PA, USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hsu, TC., Chang, CH., Lin, MC. et al. Anti-CENP-H antibodies in patients with Sjogren’s syndrome. Rheumatol Int 26, 298–303 (2006). https://doi.org/10.1007/s00296-004-0568-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-004-0568-4